4Q 22 overall in line with orders starting strongly in 2023
In FY22 LU-VE posted 2% beat on (Reuters) consensus EBITDA with results overall in line with our estimates. In Q4 22, the company generated c.13% sales increase and we estimate organic growth was HSD vs c.17% BNPPe due to lower than expected volume and pricing contributions. In Q4, adj. EBITDA was almost in line and came in at EUR c.17m, implying a 11.1% margin which is not far from last year (11.7%). FCF generation was slightly below o ....
